Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
about
The expression of the ubiquitin ligase subunit Cks1 in human breast cancerCyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancersAssociation of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progressionp27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)Novel RING E3 ubiquitin ligases in breast cancerA functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumorsA NIK-IKKα module expands ErbB2-induced tumor-initiating cells by stimulating nuclear export of p27/Kip1TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi's sarcoma-associated herpesvirusRole of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle.The MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expressionAltered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrestOncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancerSmad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoNp27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapyTReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesteroneDown-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cellsTransforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitariesTransforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancerThe cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancerReduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cellsGenomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast CancerRole of T198 modification in the regulation of p27(Kip1) protein stability and functionCyclin D1 in breast cancerPromotion of S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: association with inhibition of p27 accumulationDirect binding of the signal-transducing adaptor Grb2 facilitates down-regulation of the cyclin-dependent kinase inhibitor p27Kip1Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cellsThe ubiquitin-proteasome pathway: on protein death and cell lifeAssociations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal CancerGenetic variants of p21 and p27 and hepatocellular cancer risk in a Chinese Han population: a case-control study.Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancerp27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1.Evidence for a p27 tumor suppressive function independent of its role regulating cell proliferation in the prostate.The cyclin-dependent kinase inhibitor p27(Kip1) induces N-terminal proteolytic cleavage of cyclin A.Cell cycle regulators and their abnormalities in breast cancer.Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1).Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma.
P2860
Q21195244-DC9A0179-9FAE-46A5-A082-C4C12E956DDFQ22008565-D1B20966-C145-40E8-B8BE-A1CC717F085BQ22253912-4043F6D1-A915-419D-8D2C-7DEEE68203B0Q24294568-08EF7646-8802-46B4-AFAD-C3410EE71A26Q24298165-5CDB31D9-81B2-45A7-9743-27CD3478BF31Q24300517-AC7FC41F-7B8B-4B1C-86CB-3C67F5E1D018Q24321702-26500A9D-7DD3-4ECE-B6CA-8773A40EB89EQ24338768-D40E9F47-64EE-41DD-9747-A5B51D47CAEFQ24529076-FC3AC906-0B42-4A9E-83B8-82830E38093BQ24533560-04E89BAD-6650-44F0-91C2-33F4E6CCD081Q24534914-C62E48BF-A017-4D58-A9F0-3BFDBC61D5E6Q24536056-29CF7FDD-49AC-4CB6-8D51-0924A85C3847Q24537257-73364A8E-0C83-484F-B838-39B51090A9D5Q24553135-CB4551F9-DB26-466C-8B34-6ABA4D5072B3Q24600452-E0E8E26E-610A-44D1-A168-540C49A7F6F2Q24650994-CAD14CA5-964C-4FED-A0E7-E8CDEDCB966BQ24671974-289D42C7-2129-4B46-ABBB-07B54DCAEF73Q24672087-37D5A017-8BE3-4AF1-AC9F-8333D096E3F7Q24678553-DCA5FE7E-FD71-406E-A56A-A9C4490FAF8BQ24793291-917E1E97-90ED-4AAD-92FE-13D25DEF1135Q24793380-A0E70316-310A-41EB-8996-B80EE92835CEQ24803723-7B9D4B2B-E3BA-4D3B-BF4A-B9A50A51C7C1Q24806463-79F8B3E9-DEE4-4307-A473-0A0CFEE3B1C5Q26738987-E373CB25-3141-44FB-9CCF-ACD21196E308Q27349944-557FF5B1-C5AA-40CF-8D42-F2D8EF4CEF8CQ28138175-1BAE2175-DB21-4224-850C-CF0758C36CA1Q28205253-EDBF5ECB-799A-48F5-B991-B5BEB7D01A7CQ28208247-02FF877D-D81D-4D4C-8B2A-97F7D104554DQ28259285-939BF62F-1298-49D4-815A-40E4E22EA990Q29619270-CDF6AFF7-8B8C-49D5-9EED-13E7B190F63EQ30051055-F5C4D9F4-4726-4409-8623-94969467890CQ31102071-4CF2B4E3-40C6-4342-9FD8-D0AAB81F4205Q33250094-66559271-A18F-4049-83F8-7B963DA269FCQ33535200-BF0BB2CE-B878-443C-B990-025F5C0023A6Q33538422-9EE3EC3C-2BA6-4F6C-AC0B-FBAEBC190E36Q33564004-F9092FB3-1A01-4154-9420-586A872F34C3Q33584588-2F74AF2C-A05D-47D8-A9AD-82A9CBC373A4Q33588357-5E5F04F8-3E6E-46AD-A99E-0C99436D9E49Q33606105-DA1F8ED4-0A8B-4E95-8150-7124E40259F4Q33611310-FD6DEEB5-E9A8-49A3-83A6-08DA69EF54B7
P2860
Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Decreased levels of the cell-c ...... ions in primary breast cancer.
@ast
Decreased levels of the cell-c ...... ions in primary breast cancer.
@en
Decreased levels of the cell-c ...... ions in primary breast cancer.
@nl
type
label
Decreased levels of the cell-c ...... ions in primary breast cancer.
@ast
Decreased levels of the cell-c ...... ions in primary breast cancer.
@en
Decreased levels of the cell-c ...... ions in primary breast cancer.
@nl
prefLabel
Decreased levels of the cell-c ...... ions in primary breast cancer.
@ast
Decreased levels of the cell-c ...... ions in primary breast cancer.
@en
Decreased levels of the cell-c ...... ions in primary breast cancer.
@nl
P2093
P356
P1433
P1476
Decreased levels of the cell-c ...... ions in primary breast cancer.
@en
P2093
Bhattacharya N
Catzavelos C
Franssen E
Morava-Protzner I
Pritchard KI
Slingerland JM
P2888
P304
P356
10.1038/NM0297-227
P407
P577
1997-02-01T00:00:00Z